C57BL/6NCya-Fgf21em1flox/Cya
Common Name:
Fgf21-flox
Product ID:
S-CKO-12180
Background:
C57BL/6NCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Fgf21-flox
Strain ID
CKOCMP-56636-Fgf21-B6N-VA
Gene Name
Product ID
S-CKO-12180
Gene Alias
Fgf8c
Background
C57BL/6NCya
NCBI ID
Modification
Conditional knockout
Chromosome
7
Phenotype
Document
Application
--
Note: When using this mouse strain in a publication, please cite “C57BL/6NCya-Fgf21em1flox/Cya mice (Catalog S-CKO-12180) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000033099
NCBI RefSeq
NM_020013
Target Region
Exon 1~2
Size of Effective Region
~0.9 kb
Detailed Document
Overview of Gene Research
Fgf21, or Fibroblast growth factor 21, is a peptide hormone synthesized by multiple organs. It plays a crucial role in regulating energy homeostasis, glucose and lipid metabolism, and is involved in pathways related to energy balance. It acts through a heterodimeric receptor complex of FGF receptor 1 (FGFR1) and β -klotho [1,2]. Its diverse functions in multiple target organs, acting as an autocrine, paracrine, and endocrine factor, make it an important player in various biological processes, suggesting the value of genetic models like KO/CKO mouse models for in-depth functional studies [1].
In PTEC-specific fgf21-deficient young mice, autophagic flux increased due to higher autophagy demand, while in aged or obese fgf21-deficient mice, autophagy stagnation was exacerbated because of more severe lysosomal overburden. In aged or obese PTEC-specific fgf21-and atg5-double-deficient mice, renal histology deteriorated, mitochondrial function was severely disturbed, and oxidative stress was exacerbated compared to atg5-deficient mice. This indicates that Fgf21, induced by autophagy deficiency, protects against chronic kidney disease (CKD) progression during aging and obesity by alleviating autophagy stagnation and maintaining mitochondrial homeostasis [3].
Adiponectin knockout mice were refractory to several therapeutic benefits of FGF21, including alleviation of obesity-associated hyperglycemia, hypertriglyceridemia, insulin resistance, and hepatic steatosis, suggesting that adiponectin mediates the systemic effects of FGF21 on energy metabolism and insulin sensitivity [4].
Mice lacking either FGF21 or FGF21 signaling in the brain fail to adaptively shift macronutrient preference and increase protein intake in response to dietary protein restriction, showing that FGF21 mediates adaptive shifts in macronutrient preference to maintain protein intake during protein restriction [5].
In conclusion, Fgf21 is essential for regulating energy and macronutrient metabolism, as well as for maintaining autophagy and mitochondrial homeostasis. Gene-knockout mouse models have revealed its role in metabolic diseases such as obesity-related complications, chronic kidney disease, and the regulation of macronutrient preference, providing insights into its potential as a therapeutic target for these diseases.
References:
1. Fisher, Ffolliott Martin, Maratos-Flier, Eleftheria. 2015. Understanding the Physiology of FGF21. In Annual review of physiology, 78, 223-41. doi:10.1146/annurev-physiol-021115-105339. https://pubmed.ncbi.nlm.nih.gov/26654352/
2. Geng, Leiluo, Lam, Karen S L, Xu, Aimin. 2020. The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic. In Nature reviews. Endocrinology, 16, 654-667. doi:10.1038/s41574-020-0386-0. https://pubmed.ncbi.nlm.nih.gov/32764725/
3. Minami, Satoshi, Sakai, Shinsuke, Yamamoto, Takeshi, Matsui, Isao, Isaka, Yoshitaka. 2023. FGF21 and autophagy coordinately counteract kidney disease progression during aging and obesity. In Autophagy, 20, 489-504. doi:10.1080/15548627.2023.2259282. https://pubmed.ncbi.nlm.nih.gov/37722816/
4. Lin, Zhuofeng, Tian, Haishan, Lam, Karen S L, Xu, Aimin, Li, Xiaokun. . Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice. In Cell metabolism, 17, 779-89. doi:10.1016/j.cmet.2013.04.005. https://pubmed.ncbi.nlm.nih.gov/23663741/
5. Hill, Cristal M, Qualls-Creekmore, Emily, Berthoud, Hans-Rudolf, Münzberg, Heike, Morrison, Christopher D. . FGF21 and the Physiological Regulation of Macronutrient Preference. In Endocrinology, 161, . doi:10.1210/endocr/bqaa019. https://pubmed.ncbi.nlm.nih.gov/32047920/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen